The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation

Thrombosis Research

Volumn 97, Issue 5, 2000, Pages 349-358

  Liang, Jun F ^a   Li, Yongtao ^a   Yang, Victor C ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Fibrin(ogen); Heparin stimulation; Plasminogen activation; Template type stimulation; Tissue plasminogen activator

Indexed keywords

FIBRINOGEN; HEPARIN; PLASMINOGEN ACTIVATOR;

ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; DRUG EFFECT; FLUORESCENCE; HUMAN; PLASMINOGEN ACTIVATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

BINDING SITES; CHROMOGENIC COMPOUNDS; DEXTRAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FIBRINOGEN; HEPARIN; HUMANS; KINETICS; LIPOPROTEINS; OLIGOPEPTIDES; OSMOLAR CONCENTRATION; PLASMINOGEN; PROTEIN BINDING; PROTEIN CONFORMATION; SPECTROMETRY, FLUORESCENCE; SULFATES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0033960605     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00188-7     Document Type: Article

References (20)

1. Loscalzo J. Structural and kinetic comparison of recombinant human single- and two-chain tissue plasminogen activator. J Clin Invest. 82:1992;1391-1397.
2. Banyai L., Patthy L. Importance of intramolecular interactions in the control of the fibrin affinity and activation of human plasminogen. J Biol Chem. 259:1984;6466-6471.
3. Vinazzer H., Stemberger A., Haas S., Blümel G.B. Influence of heparin, of different heparin fractions and of a low molecular weight heparin-like substance on the mechanism of fibrinolysis. Thromb Res. 27:1982;341-352.
4. Edelberg J.M., Weissler M., Pizzo S.V. Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation. Biochem J. 276:1991;785-791.
5. Kawamura H., Watanabe I., Urano T., Takada Y., Takada A. The effects of polysaccharides on plasminogen activation by single chain-and two chain-tissue plasminogen activator. Thromb Res. 62:1991;481-490.
6. Andrade-Gordon P., Strickland S. Anticoagulant low molecular weight heparin does not enhance the activation of plasminogen by tissue plasminogen activator. J Biol Chem. 264:1989;15177-15181.
7. Andrade-Gordon P., Strickland S. Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column. Proc Natl Acad Sci USA. 87:1990;1865-1869.
8. Rijken D.C., De Munk G.A.W., Jie A.F.H. Interaction of plasminogen activators and plasminogen with heparin. Effect of ionic strength Thromb Haemost. 70:1993;867-872.
9. Weitz J.I., Kuint J., Leslie B., Hirsh J. Standard and low molecular weight heparin have no effect on tissue plasminogen activator induced plasma clot lysis or fibrinogenolysis. Thromb Haemost. 65:1991;541-544.
10. Liang J.F., Yang Y., Yu Y.T. Spectrum differencies between anti-DNA antibodies from SLE patients and normal persons. Acta Biophys Sinica. 10:1994;349-354.
11. McLean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y., Fless G.M., Scanu A.M., Lawn R.M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 330:1987;132-137.
12. Cardin A.D., Jackson R.L., Elledge B., Feldhake D. Dependence on heparin chain-length of the interaction of heparin with human plasma low density lipoproteins. Int J Biol Macromol. 11:1989;59-62.
13. Simon D.I., Fless G.M., Scanu A.M., Loscalzo J. Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein. Biochemistry. 30:1991;6671-6677.
14. Fears R. Kinetic studies on the effect of heparin and fibrin on plasminogen activators. Biochem J. 249:1988;77-81.
15. Andrade-Gordon P., Strickland S. Interaction of heparin with plasminogen activators and plasminogen. Effects on the activation of plasminogen Biochemistry. 25:1986;4033-4040.
16. Griffith M.J. Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin. J Biol Chem. 257:1982;7360-7365.
17. Weitz J.I., Leslie B., Ginsberg J. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis. J Clin Invest. 87:1991;1082-1090.
18. Griffith M.J. Kinetic analysis of the heparin-enhanced antithrombin III and thrombin reaction. Reaction rate enhancement by heparin-thrombin association. J Biol Chem. 254:1979;12044-12049.
19. Nesheim M., Fredenburgh J.C., Larsen G.R. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin. J Biol Chem. 265:1990;21541-21548.
20. Krause J., Tanswell P. Properties of molecular variants of tissue-type plasminogen activator. Arzneimittelforschung. 39:1989;632-637.